Pharmacokinetic evaluation of radiolabeled intraocular <scp>anti‐CLEC14a</scp> antibody in preclinical animal species and application in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans

Published:2022-09-27 Issue:12 Volume:15 Page:2938-2946
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Park Sohyun¹²,Lee Youn Woo³,Oh Jaeseong⁴^ORCID,Kim Su Jin³^ORCID,Lee Sukmook⁵,Lee Ho‐Young³⁶

Affiliation:

1. Department of Nuclear Medicine National Cancer Center Goyang‐si Gyeonggi‐do Korea

2. Division of Convergence Technology National Cancer Center Goyang‐si Gyeonggi‐do Korea

3. Department of Nuclear Medicine Seoul National University Bundang Hospital Seongnam‐si Gyeonggi‐do Korea

4. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Korea

5. Department of Biopharmaceutical Chemistry Kookmin University Seoul Korea

6. Office of eHealth Research and Business Seoul National University Bundang Hospital Seongnam‐si Gyeonggi‐do Korea

Funder

National Research Foundation

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13412

Reference48 articles.

1. Age-Related Macular Degeneration

2. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

3. Age-related macular degeneration

4. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

5. Ranibizumab for Neovascular Age-Related Macular Degeneration

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3